RGG-boxes of the EWS oncoprotein repress a range of transcriptional activation domains

Nucleic Acids Research

Volumn 33, Issue 4, 2005, Pages 1323-1331

  Alex, Deepa ^a   Lee, Kevin A W ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; E1A PROTEIN; LYSINE; MESSENGER RNA PRECURSOR; NUCLEIC ACID BINDING PROTEIN; PROTEIN VP16; RNA BINDING PROTEIN EWS; UNCLASSIFIED DRUG; REPRESSOR PROTEIN; TRANSACTIVATOR PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; GENE REPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STRUCTURE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; AMINO ACID SEQUENCE; CELL LINE; CHEMISTRY; DIMERIZATION; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROTEIN MOTIF; PROTEIN TERTIARY STRUCTURE; TRANSACTIVATION;

MAMMALIA;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; CELL LINE; DIMERIZATION; DNA MUTATIONAL ANALYSIS; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; REPRESSOR PROTEINS; RNA-BINDING PROTEIN EWS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS;

EID: 14544271439     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gki270     Document Type: Article

References (67)

1. Kim,J. and Pelletier,J. (1999) Molecular genetics of chromosome translocations involving EWS and related family members. Physiol. Genomics, 1, 127-138.
2. Kovar,H., Aryee,D. and Zoubek,A. (1999) The Ewing family of Tumors and the search for the Achilles heel. Curr. Opin. Oncol., 11, 275-284.
3. Arvand,A. and Denny,C.T. (2001) Biology of EWS/ETS fusions in Ewing's family tumors. Oncogene, 20, 5747-5754.
4. Zucman,J., Delattre,O., Desmaze,C., Epstein,A.L., Stenman,G., Speleman,F., Fletchers,C.D.M., Aurias,A. and Thomas,G. (1993) EWS and ATF1 gene fusion induced by t(12:22) translocation in malignant melanoma of soft parts. Nature Genet., 4, 341-345.
5. Bertolotti,A., Lutz,Y., Heard,D.J., Chambon,P. and Tora,L. (1996) hTAFII68, a novel RNA/ssDNA-binding protein with homology to the pro-oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II. EMBO J., 15, 5022-5031.
6. Haynes,S.R. (1992) The RNP Motif Protein Family. The New Biologist 4, 421-429.
7. Dreyfuss,G., Matunis,M.J., Pinol-Roma,S. and Burd,C.G. (1993) hnRNP proteins and the biogenesis of mRNA. Annu. Rev. Biochem., 62 289-321.
8. Burd,C.G. and Dreyfuss,G. (1994) Conserved structures and diversity of functions of RNA-binding proteins. Science, 265, 615-621.
9. Yang,L., Chansky,H.A. and Hickstein,D.D. (2000) EWS.Fli-1 fusion protein interacts with hyperphosphorylated RNA polymerase II and interferes with serine-arginine protein-mediated RNA splicing. J. Biol. Chem., 275, 37612-37618.
10. Knoop,L.L. and Baker,S.J. (2000) The splicing factor U1C represses EWS/ FLI-mediated transactivation. J. Biol. Chem., 275, 24865-24871.
11. Knoop,L.L. and Baker,S.J. (2001) EWS/FLI alters 5′-splice site selection. J. Biol. Chem., 276, 22317-22322.
12. Chansky,H.A., Hu,M., Hickstein,D.D. and Yang,L. (2001) Oncogenic TLS/ERG and EWS/Fli-1 fusion proteins inhibit RNA splicing mediated by YB-1 protein. Cancer Res., 61, 3586-3590.
13. Ohkura,N., Yaguchi,H., Tsukada,T. and Yamaguchi,K. (2002) The EWS/NOR1 fusion gene product gains a novel activity affecting pre-mRNA splicing. J. Biol. Chem., 277, 535-543.
14. Felsch,J.S., Lane,W.S. and Peralta,E.G. (1999) Tyrosine kinase Pyk2 mediates G-protein-coupled receptor regulation of the Ewing sarcoma RNA-binding protein EWS. Curr. Biol., 9, 485-488.
15. II68(NTD)-mediated trans-activation by v-Src. FEBS Lett., 564, 188-198.
16. Deloulme,J.C., Prichard,L., Delattre,O. and Storm,D.R. (1997) The prooncoprotein EWS binds calmodulin and is phosphorylated by protein kinase C through an IQ domain. J. Biol. Chem., 272, 27369-27377.
17. Olsen,R.R. and Hinrichs,S.H. (2001) Phosphorylation of the EWS IQ domain regulates transciptional activity of the EWS/ATF1 and EWS/FLI1 fusion proteins. Oncogene, 20, 1756-1764.
18. Zinszner,H., Sok,J., Immanuel,D., Yin,Y. and Ron,D. (1997) TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling. J. Cell Sci., 110, 1741-1750.
19. Belyanskaya,L.L., Gehrig,P.M. and Gehring,H. (2001) Exposure on cell surface and extensive arginine methylation of Ewing sarcoma (EWS) protein. J. Biol. Chem., 276, 18681-18687.
20. Brown,A.D., Lopez-Terrada,D., Denny,C.T. and Lee,K.A.W. (1995) Promoters containing ATF-binding sites are de-regulated in tumour-derived cell lines that express the EWS/ATF1 oncogene. Oncogene, 10, 1749-1756.
21. Fujimura,Y., Ohno,T., Siddique,H., Lee,L., Rao,V.N. and Reddy,E.S.P. (1996) The EWS-ATF-1 gene involved in malignant melanoma of soft parts with t(12;22) chromosome translocation, encodes a constitutive transcriptional activator. Oncogene, 12, 159-167.
22. Feng,L. and Lee, K.A.W. (2001) A repetitive element containing a critical tyrosine residue is required for transcriptional activation by the Ewings sarcoma oncogene. Oncogene, 20, 4161-4168.
23. Petermann,R., Mossier,B.M., Aryee,D.N., Khazak,V., Golemis,E.A. and Kovar,H. (1998) Oncogenic EWS-Fli1 interacts with hsRPB7, a subunit of human RNA polymerase II. Oncogene, 17, 603-610.
24. II68, and subunits of TFIID and RNA polymerase II complexes. Mol. Cell. Biol., 18, 1489-1497.
25. Hallier,M., Lerga,A., Barnache,S., Tavitian,A. and Moreau-Gachelin,F. (1998) The transcriptional factor Spi-1/PU.1 interacts with the potential splicing factor TLS. J. Biol. Chem., 273, 4838-4842.
26. Powers,C.A., Mathur,M., Raaka,B.M., Ron,D. and Samuels,H.H. (1998) TLS (Translocated-in-Liposarcoma) is a high-affinity interactor for steroid, thyroid hormone and retinoid receptors. Mol. Endocrinol., 12 4-18.
27. Uranishi,H., Tetsuka,T., Yamashita,M., Asamitsu,K., Shimizu,M., Itoh,M. and Okamoto,T. (2001) Involvement of the pro-oncoprotein TLS (Translocated in Liposarcoma) in nuclear factor-κB p65-mediated transcription as a coactivator. J. Biol. Chem., 276, 13395-13401.
28. Rossow,K.I. and Janknecht,R. (2001) The Ewing's sarcoma gene product functions as a transcriptional activator. Cancer Res., 61, 2690-2695.
29. Araya,N., Hirota,K., Shimamoto,Y., Miyagishi,M., Yoshida,E., Ishida,J., Kaneko,S., Kaneko,M., Nakajima,T. and Fukamizu,A. (2003) Cooperative interaction of EWS with CREB-binding protein selectively activates hepatocyte nuclear factor 4-mediated transcription. J. Biol. Chem. 278, 5427-5432.
30. Immanuel,D., Zinszner,H. and Ron,D. (1995) Association of SARFH (sarcoma associated RNA-binding fly homologue) with regions of chromatin transcribed by RNA polymerase II. Mol. Cell. Biol., 15, 4562-4571.
31. Li,K.K.C. and Lee,K.A.W. (2000) Transcriptional activation by the EWS oncogene can be cis-repressed by the EWS RNA-binding domain. J. Biol. Chem., 275, 23053-23058.
32. II68 displays transactivation and oncogenic properties. Oncogene 18, 8000-8010.
33. Ohno,T., Ouchida,M., Lee,L., Gatalica,Z., Rao,V.N. and Reddy,E.S.P. (1994) The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains. Oncogene 9, 3087-3097.
34. Prasad,D.D.K., Ouchida,M., Lee,L., Rao,V.N. and Reddy,E.S.P. (1994) TLS/ FUS fusion domain of TLS/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain. Oncogene, 9, 3717-3729.
35. Lerga,A., Hallier,M., Delva,L., Orvain,C., Gallais,I., Marie,J. and Moreau-Gachelin,F. (2001) Identification of an RNA binding specificity for the potential splicing factor TLS. J. Biol. Chem., 276, 6807-6816.
36. Kiledjian,M. and Dreyfuss,G. (1992) Primary structure and binding activity of the hnRNP U protein: Binding RNA through the RGG box. EMBO J., 11, 2655-2664.
37. Yang,L., Embree,L., Tsai,S. and Hickstein,D.D. (1998) Oncoprotein TLS interacts with serine-arginine proteins involved in RNA splicing. J. Biol. Chem., 273, 27761-27764.
38. Young,P.J., Francis,J.W., Lince,D., Coon,K., Androphy,E.J. and Lorson,C.L. (2003) The Ewing's sarcoma protein interacts with the Tudor domain of the survival motor neuron protein. Mol. Brain Res., 119, 37-49.
39. Costa,M., Ochem,A., Staub,A. and Falaschi,A. (1999) Human DNA helicase VIII: A DNA and RNA helicase corresponding to the G3BP protein, an element of the Ras transduction pathway. Nucleic Acids Res., 27 817-821.
40. Lee,M-H., Mori,S. and Raychaudhuri,P. (1996) trans-Activation by the hnRNP K protein involves an increase in RNA synthesis from the reporter genes. J. Biol. Chem., 271, 3420-3427.
41. Dempsey,L.A., Hanakahi,L.A. and Maizels,N. (1998) A specifc isoform of hnRNP D interacts with DNA in the LR1 heterodimer: Canonical RNA binding motifs in a sequence-specifc duplex DNA binding protein. J. Biol. Chem., 273, 29224-29229.
42. Montminy,M.R., Sevarino,K.A., Wagner,J.A., Mandel,G. and Goodman,R.H. (1986) Identification of a cyclic-AMP-responsive element within the rat somatostatin gene. Proc. Natl Acad. Sci. USA, 83, 6682-6686.
43. Emami,K.H. and Carey,M. (1992) A synergistic increase in potency of a multimerised VP16 transcriptional activation domain. EMBO J., 11, 5005-5012.
44. Krajewski,W. and Lee,K.A.W. (1994) A monomeric derivative of the cellular transcription factor CREB functions as a constitutive activator. Mol. Cell. Biol., 14, 7204-7210.
45. Pan,S., Koh,Y.M., Dunn,T.A., Li,K.K.C. and Lee,K.A.W. (1998) The EWS/ ATF1 fusion protein contains a dispersed activation domain that functions directly. Oncogene, 16, 1625-1631.
46. MacArthur,H. and Walter,G. (1984) Monoclonal antibodies specific for the carboxy terminus of Simian virus 40 large T antigen. J. Virol., 52, 483-491.
47. Ribeiro,A., Brown,A.D. and Lee,K.A.W. (1994) An in vivo assay for members of the CREB family of transcription factors. J. Biol. Chem. 269, 31124-31128.
48. Lee,K.A.W. and Masson,N. (1993) Transcriptional regulation by CREB and its relatives. Biochem. Biophys. Acta., 1174, 221-233.
49. G-Methylarginine residues in human heterogeneous RNP protein A1: Phe/Gly-Gly-Gly-Arg-Gly-Gly-Gly/Phe is a preferred recognition motif. Biochemistry, 36, 5185-5192.
50. Loriaux,M.M., Rehfuss,R.R., Brennan,R.G. and Goodman,R.H. (1993) Engineered leucine zippers show that hemiphosphorylated CREB complexes are transcriptionally active. Proc. Natl Acad. Sci. USA, 90, 9046-9050.
51. Pellar,G.J. and DiMario,P.J. (2003) Deletion and site-specific mutagenesis of nucleolin's carboxy GAR domain. Chromosoma, 111 461-469.
52. Zhou,H-Q. and Lee,K.A.W. (2001) An hsRPB4/7-dependent yeast assay for trans-activation by the EWS oncogene. Oncogene, 20, 1519-1524.
53. Oliviero,S. and Struhl,K. (1991) Synergistic transcriptional enhancement does not depend on the number of acidic activation domains bound to the promoter. Proc. Natl Acad. Sci. USA, 88, 224-228.
54. Carey,M., Kolman,J., Katz,D.A., Gradoville,L., Barberis,L. and Miller,G. (1992) Transcriptional synergy by the Epstein-Barr virus transactivator ZEBRA. J. Virol., 66, 4803-4813.
55. Herschlag,D. and Johnson,F.B. (1993) Synergism in transcriptional activation: A kinetic view. Genes Dev., 7, 173-179.
56. Brown,V., Small,K., Lakkis,L., Feng,Y., Gunter,C., Wilkinson,K.D. and Warren,S.T. (1998) Purified recombinant Fmrp exhibits selective RNA binding as an intrinsic property of the fragile X mental retardation protein. J. Biol. Chem., 273, 15521-15527.
57. Tao,J. and Frankel,A.D. (1992) Specific binding of arginine to TAR RNA. Proc. Natl Acad. Sci. USA, 89, 2723-2726.
58. Lanz,R.B., McKenna,N.J., Onate,S.A., Albrecht,U., Wong,J., Tsai,S.Y., Tsai,M-J. and O'Malley,B.W. (1999) A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell, 97, 17-27.
59. Freedman,L.P. (1999) Increasing the complexity of coactivation in nuclear receptor signaling. Cell, 97, 5-8.
60. Steinmetz,E.J. and Brow,D.A. (1998) Control of pre-mRNA accumulation by the essential yeast protein Nrd1 requires high-affinity transcript binding and a domain implicated in RNA polymerase II association. Proc. Natl Acad. Sci. USA, 95, 6699-6704.
61. Kim,M.K. and Nikodem,V.M. (1999) hnRNP U inhibits carboxy-terminal domain phosphorylation by TFIIH and represses RNA polymerase II elongation. Mol. Cell. Biol., 19, 6833-6844.
62. Yamaguchi,Y., Inukai,N., Narta,T., Wada,T. and Handa,H. (2002) Evidence that negative elongation factor represses transcription elongation through binding to a DRB sensitivity-inducing factor/RNA polymerase II complex and RNA. Mol. Cell. Biol., 22, 2918-2927.
63. Smidt,M.P., Russchen,B., Snippe,L., Wijnholds,J. and AB,G. (1995) Cloning and characterisation of a nuclear, site specific ssDNA binding protein. Nucleic Acids Res., 23, 2389-2395.
64. Ariyoshi,M. and Schwabe,J.W.R. (2003) A conserved structural motif reveals the essential transcriptional repression function of Spen proteins and their role in developmental signaling. Genes Dev., 17, 1909-1920.
65. Wang,H-Y, Wang,I-F., Bose,J. and Shen,C.K. (2004) Structural diversity and functional implications of the eukaryotic TDP gene family. Genomics, 83, 130-139.
66. Hong,W., Resnick,R.J., Rakowski,C., Shalloway,D., Taylor,S.J. and Blobel,G.A. (2002) Physical and functional interaction between the transcriptional cofactor CBP and the KH domain protein Sam68. Mol. Cancer Res., 1, 48-55.
67. Fujimura,Y., Siddique,H., Leo,L., Rao,V.N. and Reddy,E.S.P. (2001) EWS-ATF-1 chimeric protein in soft tissue clear cell sarcoma associates with CREB-binding protein and interferes with p53-mediated trans-activation function. Oncogene, 20, 6653-6659.